Caution: Investigational device. Limited by United States law to investigational use.

Transcatheter Aortic Valve Implantation (TAVI)

Transcatheter aortic valve implantation (replacement) is an investigational treatment for severe aortic stenosis. The purpose of the clinical trial is to learn whether transcatheter aortic valve implantation is a safe and effective treatment option for certain patients with severe aortic stenosis.

With transcatheter aortic valve implantation, an artificial aortic heart valve attached to a wire frame is guided by catheter (thin, flexible tube) to the heart. Once in the proper position in the heart, the wire frame expands, allowing the new aortic valve to open and begin to pump blood.

Learn more about the clinical trial. To see if you may qualify for this clinical trial, please take this short survey or connect with a participating doctor. Talk with your doctor about potential risks associated with transcatheter aortic valve implantation.


This website is not intended to be viewed by residents of the United States.

If you reside outside the USA, please click the button below.

Visit international site

Stay on U.S. site